Nonetheless, MARM2.0 is applicable not only to BRAFV600E melanoma cells (with and without EGFR overexpression) under a wide variety of conditions but also, with small modifications, to BRAFV600E NRASQ61K melanoma and BRAFV600E colorectal cancer cells. This evidence concerns the gene EGFR and melanoma.